Farmax India Limited reported audited standalone financial results for the fourth quarter and full year ended Mar. 31, 2017. For the quarter, the company reported loss from operations before, interest & exceptional items of INR 2.52 million against INR 5.6 million for the same period of last year. Loss before tax was INR 2.53 million against INR 5.56 million for the same period of last year. Net loss for the period was INR 2.53 million or INR 0.04 per basic and diluted share against INR 5.6 million or INR 0.02 per basic and diluted share for the same period of last year. Net sales/income from operations were INR 0.97 million against INR 28 million for the same period of last year. For the year, the company reported loss from operations before other income, interest & exceptional items of INR 27.6 million against INR 97.8 million for the same period of last year. Loss before tax was INR 27.6 million against INR 97.8 million for the same period of last year. Net loss for the period was INR 27.6 million or INR 0.05 per basic and diluted share against INR 97.8 million or INR 0.18 per basic and diluted share for the same period of last year. Net sales/income from operations were INR 44 million against INR 164 million for the same period of last year.